MIC
ARKG icon

Means Investment Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Means Investment Company’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,950
Closed -$660K – 192
2024
Q1 		$660K Sell
22,950
-8,220
-26% -$247K 0.09% 113
2023
Q4 		$1.02M Sell
31,170
-6,714
-18% -$183K 0.15% 92
2023
Q3 		$1.06M Sell
37,884
-3,584
-9% -$117K 0.17% 91
2023
Q2 		$1.41M Sell
41,468
-1,780
-4% -$55.9K 0.22% 82
2023
Q1 		$1.3M Sell
43,248
-932
-2% -$28.9K 0.23% 83
2022
Q4 		$1.25M Sell
44,180
-32,146
-42% -$1.02M 0.25% 81
2022
Q3 		$2.51M Buy
76,326
+484
+0.6% +$17.8K 0.54% 40
2022
Q2 		$2.39M Buy
75,842
+314
+0.4% +$11K 0.51% 43
2022
Q1 		$3.47M Buy
75,528
+753
+1% +$35.9K 0.63% 32
2021
Q4 		$4.58M Buy
74,775
+5,246
+8% +$363K 0.81% 22
2021
Q3 		$5.2M Buy
69,529
+4,786
+7% +$402K 1.03% 19
2021
Q2 		$5.99M Buy
64,743
+5,642
+10% +$480K 1.2% 19
2021
Q1 		$5.24M Buy
59,101
+2,286
+4% +$227K 1.19% 19
2020
Q4 		$6.3M Buy
56,815
+13,728
+32% +$1.09M 1.44% 14
2020
Q3 		$3.14M Buy
43,087
+19,718
+84% +$1.16M 0.86% 23
2020
Q2 		$1.31M Buy
+23,369
New +$1M 0.41% 53

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Means Investment Company's ARKG Position: Q2 2024 in Review

Means Investment Company sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 22,950 shares — an estimated $660K sold.

Means Investment Company first reported a position in ARKG in Q2 2020 and held it in 16 quarters. The position peaked at $6.3M in Q4 2020. 262 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Means Investment Company reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Means Investment Company sold 22,950 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $660K.
  • Means Investment Company first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 16 quarters.
  • Means Investment Company's ARK Genomic Revolution ETF position peaked at $6.3M in Q4 2020.
  • 262 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Means Investment Company's 13F filing for Q2 2024, filed 19 Jul 2024.